adenosine



adenosine


SMILES Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
InChIKey OIRDTQYFTABQOQ-KQYNXXCUSA-N

Chemical Properties

Hydrogen bond acceptors 9
Hydrogen bond donors 4
Rotatable bonds 2
Molecular weight (Da) 267.1

Database connections

Structure pdb 2YDO 7LD3 7LD4 6D9H 8HDP
Ligand site mutations A1 A2A A2B A3

Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

adenosine


Drug properties

Molecular type Small molecule
Physiological/Surrogate Endogenous
Approved drug Yes

Clinical Trials

Phase I 4
Phase II 16
Phase III 25
Approved Yes

Database connections

Structure pdb 2YDO 7LD3 7LD4 6D9H 8HDP
Ligand site mutations A1 A2A A2B A3

Sankey plot

Drug Information

Target Disease Phase
Gene Protein Receptor family Ligand type Class Indication name ICD11 ATC Association score Phase Approved

This ligand is endogenous.